Oncothyreon And Merck Develop Tecemodite

Oncothyreon Inc ONTY announced today that Merck KGaA's MRK biopharmaceutical business Merck Serono will be developing its antigenspecific cancer immunotherapy tecemotide previously known as Stimuvax Merck Serono will conduct a phase 3 Oncothyreon And Merck Develop Tecemodite

pfirzer and merck receive key regulatory approvals - usatoday.com shares of pfizer and merck are in the spotlight on wednesday after both companies won some key federal regulatory approvals pfizer received the backing of the centers for disease control and prevention's advisory committee on immunization practices

advaxis and merck collaborate to study novel cancer treatments - dailydigestnews.com the two companies will join together to evaluate the combination of adxspsapembrolizumab to treat prostate cancer by kate halse daily digest news monday august 25 2014 advaxis and merck collaborate to study novel cancer treatments advaxis

pfizer and merck to collaborate on study evaluating novel anti-cancer ... - marketwatch.com new york & whitehouse station nj aug 26 2014 business wire pfizer inc pfe 003% and merck & co inc mrk +095% known as msd outside the united states and canada through a subsidiary announced today that they have entered

pfizer, merck & co to assess cancer immunotherapy combo - pharmatimes.com another day another cancer immunotherapy pact and this time it's pfizer and merck & co joining forces to research the potential of another combination of two of their drugs the firms said they will explore the therapeutic potential of marrying pfizer's xalkori

bristol-myers sues merck over a patent on its new cancer drug - blogs.wsj.com the heated race between drug makers to develop and market a new type of cancer treatment – which is unfolding in laboratories and clinical trial sites – is also playing out in courtrooms as well the latest evidence emerged late last week when bristolmyers

cancer drug approval is a triumph for merck. what's next? - forbes.com the next next time someone tells you that cancer drug approval is always slow arduous and met by huge regulatory snafus consider this merck merck's keytruda was approved by the us food and drug administration just threeandahalf years after the

merck says first-of-its-type melanoma drug has received fast-track approval - njbiz.com whitehouse stationbased drugmaker merck announced thursday that the us food and drug administration has approved its drug keytruda pembrolizumab for patients with certain types of advanced melanoma merck said in a news release that

merck's advanced melanoma drug approved by fda - hngn.com the us food and drug administration fda approved merck & co's advanced treatment for melanoma called keytruda photo reuters the us food and drug administration fda approved merck & co's advanced treatment for melanoma called

bristol-myers socks merck's brand-new keytruda with pd-1 patent suit - fiercepharma.com bristolmyers squibb $bmy is doing its best to rain on merck & co's $mrk immunotherapy parade no sooner had merck won fda approval for its brandnew cancer drug keytruda pembrolizumab than bristolmyers and its partner ono pharmaceutical

weekly pharma notes: bristol-myers squibb, johnson & johnson, merck and ... - trefis.com last week saw some new drug approvals in the pharmaceutical sector while merck launched its new antipd 1 therapy roche got european union approval for expanded use of its rheumatoid arthritis drug merck's shares inched higher on the news and

View more